Thursday
May 21, 3:00pm
HSC 4E20

Colloquium announcement




Freda Miller PhD 

Professor
Department of Molecular Genetics
University of Toronto
 
"Neural Stem Cells: From Development to Repair"
Dear MiNDS students & faculty,

I am pleased to invite you to attend the MiNDS Colloquium TODAY Thursday May 21st at 3:00 in HSC 4E20. Bring your coffee cup for coffee and cookies before the talk at 2:30.

Dr. Freda Miller is a Senior Scientist at the Hospital for Sick Children and a Professor at the University of Toronto. She is an HHMI Senior International Research Scholar, a Canada Research Chair, and a Fellow of the Royal Society of Canada and the AAAS. Dr. Miller obtained her BSc. and Ph.D. in biochemistry and molecular biology, and then completed her postdoctoral training in neuroscience at the Scripps Research Foundation. She has previously held faculty positions at the University of Alberta and the Montreal Neurological Institute at McGill University prior to moving to her current position in 2002. 

Dr. Miller is best known for her studies of neural and dermal stem cells and of neuronal growth, survival and apoptosis.  Major findings from her lab have provided evidence that adult mammalian skin contains an accessible multipotent dermal stem cell that can generate peripheral neural cells, that the p75 and p63 play a critical role in determining the life, death and degeneration of mammalian neurons, and that one way genetic disorders cause cognitive dysfunction  is by perturbing embryonic neurogenesis.

In the talk today Freda will discuss the fact that one of the fundamental questions in human biology is how a pool of proliferating neural precursor cells (NPCs) in the embryo can ultimately generate the complex functional neural circuitry that comprises the adult mammalian brain. In that regard, this lecture will focus upon several aspects of that question, focusing upon the mammalian cerebral cortex and asking how NPCs are regulated both during normal development, and in genetic disorders that cause cognitive dysfunction. A second key question is whether the information that we derive from the study of developing NPCs can ultimately provide therapies for the injured or degenerating brain. An example of the potential success of such a strategy will also be discussed, focusing upon identification of pharmacological stem cell activators that can regulate signaling pathways in endogenous NPCs and in so doing, potentially enhance neural repair.   
 

 

We look forward to seeing you at the talk today. 

Regards

 

Sandra

 

---

on behalf of... 

Kathryn M Murphy PhD

Professor and Director MiNDS Graduate Program

Dept of Psychology Neuroscience & Behaviour

McMaster University

1280 Main St W 

Hamilton ON L8S 4K1